Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
hpv 16/18 vaccine (Cervarix) (1 trial)
nivolumab (opdivo) (1 trial)
atezolizumab (Tecentriq) (1 trial)
paclitaxel (taxol) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Lung Neoplasms (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Uterine Cervical Neoplasms (Phase 4)
Trials (4 total)
Trial APIs (4 total)